Individualized Pazopanib Dosing-Response
- PMID: 27980023
- DOI: 10.1158/1078-0432.CCR-16-2297
Individualized Pazopanib Dosing-Response
Comment on
-
Individualized Pazopanib Dosing: A Prospective Feasibility Study in Cancer Patients.Clin Cancer Res. 2016 Dec 1;22(23):5738-5746. doi: 10.1158/1078-0432.CCR-16-1255. Epub 2016 Jul 28. Clin Cancer Res. 2016. PMID: 27470967
-
Individualized Pazopanib Dosing-Letter.Clin Cancer Res. 2016 Dec 15;22(24):6298. doi: 10.1158/1078-0432.CCR-16-2104. Clin Cancer Res. 2016. PMID: 27980022 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources